Document Detail


The calcium-sensing receptor--a driver of colon cell differentiation.
MedLine Citation:
PMID:  19355941     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dietary Ca(2+) reduces colon cell proliferation and carcinogenesis, but it becomes ineffective or even tumor-promoting during carcinogenesis. It appears that Ca(2+) and the colon cell CaSR together brake the massive cell production in normal colon crypts. The rapid proliferation of the transit-amplifying (TA) progeny of the colon stem cells at the bases of the crypts is driven by the "Wnt" signaling mechanism that stimulates proliferogenic genes and prevents apoptogenesis. It appears that TA cell cycling stops and terminal differentiation starts when the cells reach a higher level in the crypt where there is enough external Ca(2+) to stimulate the expression of CaSRs, the signals from which stimulate the expression of E-cadherin. At this point the APC (adenomatous polyposis coli) protein appears and some of it enters the nucleus. There it removes the apoptogenesis shield and stops the beta-cateninTcf-4 complex from driving further TA cell proliferation by releasing beta-catenin from the nucleus, and delivering it to cytoplasmic APCaxinGSK-3beta complexes for ultimate proteasomal destruction. Cytoplasmic beta-catenin is prevented from returning to the nucleus by destruction in APCaxinGSK-3beta complexes or locked by the emerging E-cadherin into adherens junctions which link the cell to proliferatively shut-down functioning cells with APC-dependent cytoskeletons moving up and out of the crypt. A common first step in colon carcinogenesis is the loss of functional APC which results in the retention of proliferogenic nuclear beta-cateninTcf-4. This drives the eventual appearance of mutation accumulating, apoptosis-resistant clones the proliferation of which cannot be inhibited by external Ca(2+) because of CaSR-disabling gene mutations.
Authors:
J F Whitfield
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  10     ISSN:  1873-4316     ISO Abbreviation:  Curr Pharm Biotechnol     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-09     Completed Date:  2009-06-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  311-6     Citation Subset:  IM    
Affiliation:
Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada. pthosteo@rogers.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects
Cell Differentiation / physiology*
Colon / cytology*,  physiology
Humans
Intestinal Mucosa / cytology,  drug effects
Neoplasms / pathology
Receptors, Calcium-Sensing / physiology*
Chemical
Reg. No./Substance:
0/Receptors, Calcium-Sensing

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport.
Next Document:  Calcium-sensing receptor (CaSR) in human brain's pathophysiology: roles in late-onset Alzheimer's di...